Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
05/12/2010 | EP2099762B1 Antibacterial quinoline derivatives |
05/12/2010 | EP2066318B1 Oxindole derivatives as anticancer agents |
05/12/2010 | EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
05/12/2010 | EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
05/12/2010 | CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof |
05/12/2010 | CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists |
05/12/2010 | CN1798559B Quinoline-2-one-derivatives for the treatment of airways diseases |
05/12/2010 | CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
05/12/2010 | CN101704813A 1'-thio-indigo red compound as well as application and preparation method thereof |
05/12/2010 | CN101704810A Cycloalkyl inhibitors of potassium channel function |
05/12/2010 | CN101704797A compounds effecting glucokinase |
05/11/2010 | US7713964 Methods for treating asthmatic conditions |
05/11/2010 | CA2456095C An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) |
05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
05/11/2010 | CA2410177C Thrombin receptor antagonists |
05/11/2010 | CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
05/06/2010 | WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
05/06/2010 | WO2010027746A3 Hedgehog pathway modulators |
05/06/2010 | WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
05/06/2010 | WO2009149381A3 Chemical framework compositions and methods of use |
05/06/2010 | WO2009132832A3 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives |
05/06/2010 | US20100113579 Prodrugs of excitatory amino acids |
05/06/2010 | US20100113549 Pyrrolidine compounds |
05/06/2010 | US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof |
05/06/2010 | US20100113467 Organic Compounds |
05/06/2010 | US20100113464 Novel pyridazine derivatives |
05/06/2010 | US20100113430 Thioxanthene derivates useful to treat infectious diseases |
05/06/2010 | US20100113423 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof |
05/06/2010 | US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
05/06/2010 | CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same |
05/05/2010 | EP2181985A1 Antiviral Agent |
05/05/2010 | EP2181109A2 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
05/05/2010 | EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
05/05/2010 | EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |
05/05/2010 | EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections |
05/05/2010 | EP1558607B1 Compositions useful as inhibitors of rock and other protein kinases |
05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
05/05/2010 | CN1930157B Silylierte carboxamide |
05/05/2010 | CN1706839B Material containing non-benzenoid aryl spiro and its synthesis and application |
05/05/2010 | CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same |
05/05/2010 | CN101702907A Piperazine compounds with a herbicidal action |
05/05/2010 | CN101701017A New preparation method of lanoconazole |
05/05/2010 | CN101056859B Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand |
05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
05/04/2010 | US7709528 Compounds, their preparation and use |
05/04/2010 | US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration |
05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
05/04/2010 | US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes |
05/04/2010 | US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate; |
05/04/2010 | US7709500 Chemical compounds |
05/04/2010 | US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
05/04/2010 | US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides |
05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
05/04/2010 | US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia |
05/04/2010 | US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
05/04/2010 | CA2439001C Water-soluble triazole antifungal agents |
04/29/2010 | WO2010048207A2 Aryl gpr120 receptor agonists and uses thereof |
04/29/2010 | WO2010048131A1 C-met protein kinase inhibitors |
04/29/2010 | WO2010047295A1 Medicine for preventing or treating pain related to herpes zoster |
04/29/2010 | WO2010046912A2 Thiophene containing analogues of fluconazole as antifungal agents and process thereof |
04/29/2010 | WO2010046780A2 Anti viral compounds |
04/29/2010 | WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists |
04/29/2010 | WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy |
04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
04/29/2010 | US20100105905 EP2 Agonists |
04/29/2010 | US20100105896 Pharmaceutical compounds |
04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
04/29/2010 | US20100105767 Compounds, compositions and methods |
04/29/2010 | US20100105729 Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents |
04/29/2010 | US20100105719 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
04/29/2010 | DE10042603B4 Photochrome Verbindung und ihre Verwendung in optischen Funktionsvorrichtungen Photochromic compound and their use in optical function devices |
04/29/2010 | CA2740583A1 C-met protein kinase inhibitors |
04/29/2010 | CA2740366A1 Aryl gpr120 receptor agonists and uses thereof |
04/29/2010 | CA2739946A1 Isoquinolinone derivatives as nk3 antagonists |
04/29/2010 | CA2728949A1 Thiophene containing analogues of fluconazole as antifungal agents and process thereof |
04/28/2010 | EP2180020A1 Indolium compound and optical recording material using the compound |
04/28/2010 | EP2178859A2 Condensed anthranilamide derivatives as insectisides |
04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
04/28/2010 | EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity |
04/28/2010 | EP2178835A1 Novel substituted piperidones as hsp inducers |
04/28/2010 | EP1907366B1 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
04/28/2010 | EP1720837B1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
04/28/2010 | EP1678162B1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
04/28/2010 | EP1482002B1 Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition |
04/28/2010 | CN1978444B Photochromic thiophene pyrrole mixed linkage type dithienylethene compounds, and their synthesizing and use |
04/28/2010 | CN1856305B Pyridine derivatives as urotensin II antagonists |
04/28/2010 | CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |
04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
04/27/2010 | US7705031 Benzimidazoles useful as modulators of ion channels |
04/27/2010 | US7705029 Acrylonitrile derivatives for inflammation and immune-related uses |
04/27/2010 | US7705017 Compounds for treatment of neurodegenerative diseases |
04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |